Curia


Curia is a global contract research, development, and manufacturing organization with over 30 years of experience. It offers services across drug discovery, development, manufacturing, and biologics, backed by scientific expertise and a global network of facilities. Curia aims to accelerate the delivery of therapies to patients through flexible, scalable solutions and a commitment to quality and innovation.

Industries

Health Care
Biotechnology
Manufacturing
Pharmaceutical Manufacturing

Nr. of Employees

Very Large (1000+)


Patents

Morphic forms of G1T38 and methods of manufacture thereof

US-12139494-B2

View Details

Choline salt forms of an HIV capsid inhibitor

US-11833143-B2

View Details

Solid forms of a toll-like receptor modulator

US-11773098-B2

View Details

Compounds for improving mRNA splicing

US-11702417-B2

View Details

Synthesis of N-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines

US-11629150-B2

View Details

Methods and processes for the preparation of KDM1A inhibitors

US-11390590-B2

View Details
View All Patents

Products

TunaCHO platform

A proprietary CHO transient production technology platform that solves the technical problem of low transient transfection efficiency, achieving production yields greater than 1 gram per liter in shake flasks.

TunaCHO TM platform

A proprietary technology platform for CHO transient production, delivering high production yield compared to other commercial cell lines.

High Potency API Manufacturing

Custom development and cGMP production services for highly potent compounds, from grams to hundreds of kilograms per year, leveraging SafeBridge-certified facilities and specialized containment technology.

Developability Package 1

In silico sequence liability analysis and immunogenicity analysis for rapid assessment of drug candidates.

Developability Package 3

Comprehensive formulation study including buffer exchange, forced degradation, integrity and stability assessment, and additional stress conditions.

Developability Package II

Comprehensive evaluation covering polyspecificity, integrity, stability, aggregation, purity, charge variant, thermostability, and post-translational modifications.

View All Products

Services

Hit‑to‑lead discovery services including assay development, in‑vitro biology, medicinal chemistry, structural biology and computational design.

Chemical process R&D, custom synthesis, high‑potency handling and GMP API production from kilograms to commercial scale.

Antibody discovery, single‑cell screening, developability assessment, recombinant antibody production and cell engineering to progress programs into development.

mRNA and self‑replicating RNA process development, analytical support and GMP production, and downstream formulation into lipid nanoparticle systems.

Formulation development, process development, clinical and commercial sterile fill–finish, lyophilization and packaging for parenteral products.

Method development and validation, batch release testing, stability studies and solid‑state chemistry to support regulatory submissions and product release.

View All Services

Expertise Areas

  • Clinical manufacturing and sterile fill–finish
  • Small‑molecule process development and API manufacturing
  • Biologics discovery, cell‑line development and bioprocessing
  • mRNA and long‑RNA (srRNA) development and manufacture
  • Show More (6)

Key Technologies

  • GMP manufacturing
  • Isolator‑based vial filling and automated fill–finish lines
  • Lyophilization (freeze‑drying)
  • Lipid nanoparticle (LNP) formulation
  • Show More (9)

News & Updates

Scheduled for July 21-23, 2025, in Boston, MA. Booth: 24.

AMRI was recognized in capabilities, compatibility, expertise, quality, reliability, and service based on small pharma respondents in primary market research.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.